Matches in Nanopublications for { ?s ?p "[Peripheral endocannabinoid overactivity might explain why CB(1) blockers cause weight-loss independent reduction of lipogenesis, of hypoadiponectinemia, and of hyperinsulinemia in obese animals and humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion description "[Peripheral endocannabinoid overactivity might explain why CB(1) blockers cause weight-loss independent reduction of lipogenesis, of hypoadiponectinemia, and of hyperinsulinemia in obese animals and humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.